Frontlight ResearchEarly access
Trial site
Clinica de Pesquisas e Centro de Estudos Em Oncologia Ginecologica e Mamaria Ltda
- 6running trials
- 2closed trials
The trials here
What the 8 trials at this site are about, from their registry records.
- Conditions
- Metastatic breast cancer7 trials
- Colorectal cancer1 trial
- Lung cancer1 trial
- Triple-negative breast cancer1 trial
- Phase
- Phase 34 trials
- Phase 22 trials
- Phase 11 trial
- Phase 2/31 trial
- Status
- Recruiting4 trials
- Active, not recruiting2 trials
- Completed2 trials
- Lead sponsor
- Daiichi Sankyo2 trials
- Eli Lilly and Company2 trials
- Bristol-Myers Squibb1 trial
- Seagen, a wholly owned subsidiary of Pfizer1 trial
- Stemline Therapeutics, Inc.1 trial
- and 1 more
Running trials
Recruiting
Recruiting
Recruiting
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
Recruiting
Active, not recruiting
Active, not recruiting
A Study of Tucatinib or Placebo With Trastuzumab and Pertuzumab for Metastatic HER2+ Breast Cancer
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Metastatic breast cancer3 recruiting
- Colorectal cancer1 recruiting
- Lung cancer1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Completed
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026